All posts by imreal

DocASAP Wins The 2019 eHealthcare Leadership Awards for “Best Online Appointment Scheduling”


News Image

“DocASAP is honored to be recognized as one of the healthcare industry’s leading technology providers for our innovative online appointment scheduling solution that’s part of our patient access and engagement platform,” said Puneet Maheshwari, co-founder and CEO of DocASAP.

DocASAP, the most advanced patient access and engagement platform for health systems, health plans and physician groups, today announced it was selected as a winner of the 2019 eHealthcare Leadership awards program, under the Online Appointment Scheduling category. The annual nation-wide awards program distinguishes the top websites and digital initiatives in the healthcare industry.

“DocASAP is honored to be recognized as one of the healthcare industry’s leading technology providers for our innovative online appointment scheduling solution that’s part of our patient access and engagement platform,” said Puneet Maheshwari, co-founder and CEO of DocASAP. “DocASAP is dedicated to enhancing the patient experience and providing seamless access to world-class healthcare. This award further underscores our commitment to optimizing access to care by navigating patients to the right provider and care setting at the right time.”

DocASAP’s platform helps health systems, health plans and physician groups navigate patients and health plan members to optimal care throughout the healthcare journey to help improve outcomes, reduce costs and create a better experience. DocASAP’s provider search and navigation solution helps streamline access to care by matching patient demographics, insurance, clinical and timely care needs with provider credentials and availability. It handles the complexities of patient-provider matching by automating provider-specific scheduling intake rules, protocols and workflows.

DocASAP’s online scheduling solution facilitates real-time, accurate online appointment scheduling and integrates with practice management systems, helping deliver the frictionless access consumers demand. It now also accommodates non-traditional visit types, such as telehealth/virtual appointments, walk-ins, home visits and phone appointments.

Additionally, DocASAP’s recently launched point of care and access center capabilities to optimize care coordination across the enterprise, helping improve efficiencies and enhance the patient experience. DocASAP’s care-driven reminder solutions enables healthcare providers to engage patients pre and post-visit to encourage proactive and coordinated care management, helping close gaps in care and reduce no shows.

The “eHealthcare Leadership” awards program draws more than 1,000 entries a year and exclusively recognizes the very best websites and digital communications of healthcare organizations, online health companies, pharmaceutical/medical equipment firms, agencies/suppliers and business improvement initiatives. Presented by both eHealthcare Strategy & Trends Magazine and Strategic Health Care Marketing Magazine, the awards program highlights the role of digital communications in achieving healthcare organizations’ business objectives.

To view the full list of 2019 “eHealthcare Leadership” award winners, visit: https://ehealthcareawards.com/2019-winners/

About DocASAP

DocASAP provides the leading patient access and engagement platform for health systems, health plans and physician groups. The platform addresses one of healthcare’s biggest challenges – access to care – by helping navigate patients and members to the right provider and care setting at the right time. Backed and promoted in the market by Aetna and UnitedHealthcare, DocASAP builds unique payer-provider connections with an eye towards simplified access, increased care compliance and improved population risk management. DocASAP’s provider search and navigation, consumer-facing and access center scheduling, provider data management and care driven reminders help optimize access throughout the healthcare journey to improve outcomes, reduce costs and create a better experience. For more information, visit http://docasap.com or follow on Twitter @DocASAP.

Share article on social media or email:

Mesa Science Associates and Bryn Pharma Announce Initial Study of a New Approach to Treating Anaphylaxis


News Image

On November 10, 2019, Mr. Michael Mesa, President, and CEO of Mesa Science Associates (MSA), announced the presentation of a non-clinical study regarding Nasal Administration of Epinephrine. The results were presented by Kenneth Dretchen Ph.D., CSO and Principle Investigator at MSA. The study was presented in a poster at the American College of Allergy, Asthma, and Immunology (ACAAI) annual conference in Houston, Texas on November 10, 2019. The poster entitled, “Intranasal Effects on Pharmacokinetics and Heart Rate in a Nasal Congestion Canine Model” is the first in a series of publications to be presented by MSA that detail the results of non-clinical studies conducted to support the concept of Nasal Administration of Epinephrine for patients suffering from a severe allergic reaction, commonly known as anaphylaxis. MSA and MRI Global of Kansas City, MO. collaborated on the study which was funded by Bryn Pharma LLC. The study was conducted to determine the ability of epinephrine to be absorbed through the nasal mucosa and to determine blood levels and pharmacokinetic values when the drug is applied nasally to dogs that have nasal congestion. The nasal congestion was induced by continuous exposure to histamine throughout the test period. This study has shown that even with nasal congestion present the nasal route of administration of epinephrine in canines produce even higher plasma levels of the drug as compared to the intramuscular route of administration.

The current therapy to treat an anaphylactic event is the administration of epinephrine by intramuscular injection via an auto-injector. While this treatment has shown to be effective, problems with auto-injectors include patient concerns about needles that can lead to avoidance, delayed therapy, or even injury at the injection site. Bryn Pharma, a North Carolina based company, is developing a new cost-effective two-dose nasally administered therapy that has the potential to mitigate most of the issues with autoinjector administration. The device is a small compact unit that is needle-free and easy to carry in pockets or purses. MSA is under contract to support the Bryn effort through commercial launch.

Mesa Science Associates is a pharmaceutical product development company located inside the Frederick Innovation and Technology Center Inc. (FITCI) in Frederick MD. The goal of the company is to provide technical and scientific expertise to researchers from all aspects of the drug, drug delivery and product development community, including researchers from the government, academia, and private entities.

Share article on social media or email:

Ushio America Introduces the Theia™ Series, an Illuminator and Video Processor System for Microendoscopy Applications


Theia Microendoscopy System

Theia Microendoscopy System

Available in a 40k-pixel and 160k-pixel resolution model, the system includes crisp and vibrant color images in the hardest to reach locations by matching some of the highest resolution CMOS cameras with the smallest videoscope sizes available.

Ushio America, Inc. proudly introduces the Theia™ series, a combined illuminator and video processor system for research and original equipment manufacturers (OEMs) in microendoscopy applications. Available in a 40k-pixel and 160k-pixel resolution model, the system includes crisp and vibrant color images in the hardest to reach locations by matching some of the highest resolution CMOS cameras with the smallest videoscope sizes available. The video processor is capable of handling massive image and digital signal processing applications using a field-programmable gate array (FPGA).

The Theia 40 model has an active image sensor of 200µm x 200µm producing 40k-pixel resolution with a 3-50mm depth of focus and it is deal for 1.1mm outside diameter (OD) flexible endoscope and 2-6mm steerable endoscope applications. The Theia 40 automatically adjusts the LED output to maintain a properly illuminated image. The Theia 160 model has an active image sensor of 400µm x 400µm producing 160k-pixel resolution with a 5-50mm depth of focus. The Theia 160 video processor has auto-gain and auto-exposure, and it is ideal for flexible endoscopes 1.7mm OD or larger and 3-6mm steerable endoscope applications.

Both standard models have video output of 30 frames per second (fps), and the standard 6500K color temperature LED delivers uniform white light with up to four fibers surrounding a videoscope with 120º field of view (FOV). Additional product customizations are available including a wide array of endoscope diameters, rigid or flexible scopes, and a range of endoscope lengths.

For more information on the Theia series, visit http://www.ushio.com/medical-systems/ or call +1.802.877.2182.

About Ushio America, Inc.

Ushio America, Inc. is a vertically integrated solutions company for lighting systems and components utilizing xenon short arc, lasers, ultra-high-pressure UV, excimer, metal halide, LEDs (specialty sensing and architectural lighting), halogen, fluorescent, and miniature incandescent lamps serving semiconductor, printed circuit, video projection, cinema, medical, life sciences, UV curing, germicidal, horticulture, landscaping, graphic arts, flashlight, scientific, medical, infra-red heating, lamp and laser drivers, systems and services, and numerous other applications. Established in 1967 as a subsidiary of Ushio Inc., in Tokyo, Japan, Ushio America offers a full spectrum of over 2,500 products and services to its customers. For more information, visit http://www.ushio.com.

Share article on social media or email:

Greenberg Traurig’s David J. Dykeman Co-Chairs CJP Health Professions Annual Breakfast


David J. Dykeman, patent attorney and co-chair of Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group and Boston Intellectual Property & Technology (IP) Group will co-chair the Combined Jewish Philanthropies (CJP) Health Professions Annual Breakfast, Nov. 17 at 9:00 a.m. at the Royal Sonesta Boston. Greenberg Traurig is a sponsor of the event.

The event, which is co-chaired by Rachel Wolfberg, Pharm.D., Dana-Farber Cancer Institute, brings together medical professionals, senior executives, entrepreneurs, and investors from across the biotech, pharma, healthcare, medtech, and diagnostics industries to strengthen business relationships within the Greater Boston Jewish community. Keynote speaker Adam M. Koppel, M.D., Ph.D., Managing Director, Bain Capital Life Sciences, will discuss, “How Innovation is Improving Delivery of Medical Care — Creating Value for Patients and Investors.” In addition, attendees will honor Beverly Siegal, M.D., M.P.H. with The Lewis H. Millender Community of Excellence Award.

Prior to the breakfast, Dykeman, who also serves as the Healthcare Innovations Network (HIN) Chair, will host a special HIN pre-reception at 8:00 a.m. Guest speaker Sophie Kornowski, Pharm.D., MBA and Senior Partner, Gurnet Point Capital, will discuss “An Insider’s View on Dealmaking in Pharma and Biotech Ventures.”

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law

Share article on social media or email:

The University of North Carolina Kenan-Flagler Business School Honors Graduates Who Earned MBAs While Working


News Image

“By earning their MBAs, these business leaders can celebrate their wise investment in themselves, both professionally and personally,” said Bradley Staats, associate dean of MBA Programs.

The University of North Carolina Kenan-Flagler Business School celebrated the graduation of 333 working professionals from its evening, weekend and online MBA programs on Nov. 9 at the Dean E. Smith Center.

“By earning their MBAs, these business leaders can celebrate their wise investment in themselves, both professionally and personally,” said Bradley Staats, associate dean of MBA Programs and an operations professor. “They studied – learning from each other as well as their professors – and took those lessons back to work to benefit their organizations. The strong bonds they built with their classmates now extend to an even wider network of more than 38,000 alumni in 50 states and 85 countries who are passionate about UNC Kenan-Flagler.”

Graduates of the Evening Program are from the Triangle, while graduates of the Weekend Program come from as far away as California, Rhode Island, New York, Tennessee and Georgia. Graduates of the online program live across the U.S. and in Canada and Italy.

They work in diverse industries and for small first to multinational organizations. Some of the organizations for which they work include Bank of America, Blue Cross Blue Shield, BP, GE Aviation, IBM, JP Morgan Chase, Lenovo, MITRE Corporation, Red Hat, UNC School of Medicine, U.S. Army and U.S. Marine Corps.

Stephen Cumbie (MBA ’73), chief executive officer and principal of NVCommercial Inc., NVRetail Inc. and Metro Management Services LLC, gave the keynote address.

Teaching excellence awards were presented to Hugh O’Neill, professor of strategy and entrepreneurship and Edward M. O’Herron, Jr. Distinguished Scholar; Christian Lundblad, Richard “Dick” Levin Distinguished Professor of Finance; and Amanda Thompson, clinical assistant professor of finance.

About the University of North Carolina Kenan-Flagler Business School

Consistently ranked one of the world’s best business schools, UNC Kenan-Flagler offers a broad range of programs – Undergraduate, MBA and Master of Accounting, PhD and Executive Development – and extraordinary, real-life learning experiences. Faculty demonstrate unparalleled dedication to students’ learning and a commitment to world-class research that addresses critical business challenges. Contributing to the School’s thought leadership is the Frank Hawkins Kenan Institute of Private Enterprise, which promotes innovative, market-based solutions to vital economic issues. UNC Kenan-Flagler’s collaborative culture is rooted in core values that date back to its founding in 1919, and graduates are renowned as effective, principled leaders with the technical knowledge and leadership skills to deliver results in the global business environment.

Share article on social media or email:

Internal Medicine Specialist, Prabhat Sinha, M.D. Named 2019 NJ Top Doc


Dr. Prabhat Sinha

Dr. Prabhat Sinha

Prabhat Sinha, M.D. of Ocean Family & Geriatric Associates, LLC has been reviewed and approved by NJ Top Docs for the second consecutive year. Treating patients of all ages while specializing in internal medicine and geriatric medicine, Dr. Sinha makes it a priority to go above and beyond in his patient care. With a board-certification in internal medicine, use of the most up-to-date technology, and a patient-centered approach to care, Dr. Sinha provides the best possible care for his patients.

At Ocean Family & Geriatric Associates, Dr. Sinha and his staff put their patients first. Trust is a key point of their practice philosophy. Dr. Sinha’s caring nature allows him to be thorough and spend ample time with each patient during their appointment, which his patients love and look forward to. Dr. Sinha strives to create deep patient relationships and has said, “My favorite part of the day is my interaction with the patients, because the patients are so appreciative of all we do for them.”

Services provided by Dr. Sinha include Pulmonary Function Tests for COPD and Asthma, Electrocardiograms, Botox Injections, Suboxone Treatment for Opiate Addiction, Arterial Brachial Index for PAD, Nerve Conduction Study for Neuropathy, B12 Injections, Weight Loss Management, Arthritis Care, Anti-Aging Treatment through Bio-Identical Hormone Placement, and Hair Restoration by Platelet-Rich Infusions.

To learn more about Dr. Sinha, please click the following link to visit his custom NJ Top Docs webpage: https://njtopdocs.com/nj-doctors/prabhat-sinha-md/

About Us

NJ Top Docs a comprehensive, trusted, and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook and Twitter

Share article on social media or email:



Jessica Horton Pickard’s newly released “Mindy’s Light” is an inspiring story of a young girl who loves Jesus the most


News Image

“Mindy’s Light”: a brimful storybook that allows the readers to know more about Christ and His deeds as the Messiah who saved the world from sins. “Mindy’s Light” is the creation of published author Jessica Horton Pickard, a writer who has a strong faith and connection to God.

Pickard writes, “Mindy’s Light illustrates the gift of salvation. For Mindy, summer meant mud puddles, berry picking, and running barefoot. She loved her family and the adventures she shared with them. But she loved Jesus more. Even though Mindy knew of the love of Jesus, she had not yet received her little light. Throughout the summer, Mindy kept having these tugs on her heart. With each tug, Mindy asked her daddy more and more questions. ‘What is a sin?’ ‘Why do you get baptized?’ and ‘What does being baptized mean?’ Mindy’s daddy answers her questions with scripture. More importantly, Mindy’s daddy shows her in the Bible what it means to ask Jesus in her heart. But it can only be when her heart is ready.

“Mindy’s sweet journey to salvation is a story that not only demonstrates receiving the light of Jesus but also portrays how we should pray for our children.”

Published by Christian Faith Publishing, Pickard’s new book touches and opens the hearts of the readers allowing them to accept the Only Begotten Son of the Lord and urges them to love Jesus the way Mindy loves Him.

With this purpose, the author aims to encourage the readers to open their hearts, accept, and welcome Jesus in their lives.

View a synopsis of “Mindy’s Light” on YouTube.

Consumers can purchase “Mindy’s Light” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Mindy’s Light,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Heilind Electronics Adds American Sensor Technologies (AST) to TE Connectivity Portfolio


AST harsh environment industrial sensors

The addition of AST gives Heilind customers access to a more diverse range of harsh environment industrial sensors, including custom solutions.

Heilind Electronics, a premier distributor of electronic components worldwide, has partnered with TE Connectivity (TE) to bring its customers an extensive range of harsh environment pressure and liquid level sensors. The new products are part of TE’s American Sensor Technologies (AST) brand, which complements the distributor’s existing TE Measurement Specialties solutions.

A key part of Heilind’s new AST offering is hazardous location pressure transducers. These items are certified to CSA, UL, ATEX and other standards that qualify them as explosion proof, intrinsically safe or non-incendive. In addition, customers can request customized designs and configure options like process connections, materials, pressure ranges and output.

Accommodating pressure ranges from vacuum to 20,000 PSI, AST sensors feature high-strength construction without the use of oil, welds or internal O-rings. The sensors are used to monitor pressure, differential pressure and liquid level in low-to-medium volume OEM applications like compressed natural gas (CNG) stations, onshore/offshore drilling equipment and telemetry equipment.

“We are pleased to add AST to our TE Connectivity sensor portfolio,” said Alan Clapp, Vice President, Heilind Electronics. “AST is recognized as an industry leader, with custom-engineered pressure sensors designed specifically for harsh and hazardous environments. Therefore, we can offer customers a virtually unlimited number of configurations for applications where such performance is required — including the oil and gas marketplace.”

Visit Heilind’s website for more information on American Sensor Technologies solutions.

About Heilind Electronics

Heilind Electronics, Inc. (http://www.heilind.com) is one of the world’s leading distributors of connectors, relays, sensors, switches, thermal management and circuit protection products, terminal blocks, wire and cable, wiring accessories and insulation and identification products. Founded in 1974, Heilind has locations throughout the U.S., Canada, Mexico, Brazil, Germany, Singapore, Hong Kong and China. Follow Heilind on Facebook at facebook.com/Heilind and on Twitter at twitter.com/Heilind.

About TE Connectivity

TE Connectivity Ltd. (http://www.te.com) is a $13 billion global industrial technology leader creating a safer, sustainable, productive and connected future. TE’s broad range of connectivity and sensor solutions, proven in the harshest environments, enable advancements in transportation, industrial applications, medical technology, energy, data communications and the home. With nearly 80,000 employees, including more than 8,000 engineers working alongside customers in approximately 150 countries, TE ensures that EVERY CONNECTION COUNTS.

Share article on social media or email:



Senior Regulatory Affairs and Program Management Executive, Robert Peterson, RAC, Joins NDA Partners


News Image

Mr. Peterson’s extensive experience leading cross-functional regulatory and product development teams in both small and large companies will bring great value to our clients who need full support for their product development programs.

NDA Partners Chairman Carl Peck, MD, announced today that Robert Peterson, RAC, a regulatory affairs and program management executive with more than 33 years of regulatory and product development experience in the biopharmaceutical and medical device industries, has joined the firm as an Expert Consultant.

Robert Peterson has extensive experience in formulating and executing regulatory, clinical, and product development strategies, interfacing with regulatory agencies, and filing regulatory submissions. In addition, he has extensive hands-on experience in research and development, manufacturing, nonclinical and clinical studies, and leading cross-functional teams in both small and large companies.

Most recently, Mr. Peterson was Executive Director of Regulatory Affairs at Liquidia Technologies Inc. He has also served as Vice President of Product Development and Regulatory Affairs at Nephrogenex Inc., Director of Research and Development at Cardiopolymers Inc., and Director of Product Development at Biostratum Inc. In his early career, he served as Director of Research and Development in the Vascular Division at Baxter Healthcare.

“Mr. Peterson’s extensive experience leading cross-functional regulatory and product development teams in both small and large companies will bring great value to our clients who need full support for their product development programs,” said Dr. Peck. “We are pleased to welcome him to NDA Partners.”

Robert Peterson earned his Master of Engineering degree in biomedical engineering from the University of California, Berkeley and his Bachelor of Science degree in engineering from the United States Military Academy at West Point, New York.

About NDA Partners

NDA Partners is a life sciences management consulting and contract development organization (CDO) focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Principals and Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and contract management of client product development programs.

Contact

Earle Martin, Chief Executive Officer

Office: 540-738-2550

MartinEarle@ndapartners.com

Share article on social media or email:

Chapters Health System Names New Chief Business Development Officer


Paola Delp, Chapters Health System, Chief Business Development Officer

Paola Bianchi Delp, MHA, MBA, ACHE, Chapters Health System, Chief Business Development Officer

“It became readily apparent that having Paola as a permanent team member was vitally important in order for the organization to meet our strategic goals.” Andrew Molosky, MBA, FACHE, CHPCA, president and chief executive officer at Chapters Health.

Chapters Health System, one of the nation’s premier not-for-profit, community-based healthcare organizations headquartered in Temple Terrace, names Paola Bianchi Delp, MHA, MBA, ACHE, as the organization’s new chief business development officer. Delp will be responsible for overseeing and expanding relationships with payors, hospital systems and assist in the development of additional strategic partnerships for Chapters Health.

“In December 2018, Paola joined the organization as a consultant, whereby she assisted us in reviewing and analyzing our existing managed care contracts. As time passed, it became readily apparent that having Paola as a permanent team member was vitally important in order for the organization to meet our strategic goals,” said Andrew Molosky, MBA, FACHE, CHPCA, president and chief executive officer at Chapters Health.

“For us at Chapters Health, Paola brings more than 25 years of experience in leading hospitals, medical groups, integrated delivery systems and health plans in terms of their operations, management, business development and strategic programs. She is a pioneer in the creation of risk-based delivery models, which allowed her to launch several alliances with independent physician associations, physician-hospital organizations, and Medicare-shared savings and accountable care organizations (ACO) programs,” added Dave O’Neil, chief financial officer at Chapters Health.

For the past eight years, Delp consulted in the areas of ACOs, population health and value-based outcomes for healthcare organizations across the United States. Prior to launching her consultant company, she served in a variety of leadership roles for United Healthcare, Physician Healthcare Plans, Ramsay-HMO as well as a number of hospital systems.

Delp received her Bachelor of Science degree in management and public relations from the University of Florida and she earned master’s degrees in both healthcare administration and business administration from the University of South Florida. She is a member of the American College of Healthcare Executives and served on the board of the American Hospital Association Managed Care. In addition, Delp has authored and advocated to modify claim payment accountability with payors.

About Chapters Health System

As a progressive leader and premier health system, Chapters Health System is dedicated to delivering innovative home health, palliative and hospice care along with durable medical equipment and pharmacy services. Since 1983 as a community-based, not-for-profit organization, Chapters Health has provided choices, education and guidance through its managed affiliates: Chapters Health Home Care, Chapters Health Palliative Care, Good Shepherd Hospice, Hospice of Okeechobee, HPH Hospice and LifePath Hospice, located in Citrus, Hardee, Hernando, Highlands, Hillsborough, Martin, Okeechobee, Pasco, Pinellas, Polk and St. Lucie counties. All offerings are provided in order to improve the patient/family experience well in advance of end-of-life needs. To learn more, visit http://www.chaptershealth.org, like us on Facebook or follow us on Twitter and LinkedIn.

Share article on social media or email: